News

GRCU

St. Jude Medical Up on Affirmed Rating, Looming FDA Review Date

Jacob Harper | Equities.com |

Medical devicemaker St. Jude Medical, Inc. (STJ) popped on Sept 6 following two separate pieces of good news. The FDA set a date to review their subsidiary product the Champion Heart Failure


Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     

INTERVIEW: CEO Steve Stanulis - Stanulis Films

Equities.com's Sam Mitchell interviewing CEO Steve Stanulis of Stanulis Films.